Is this email not displaying correctly? View it in your browser.
 
Newswise - News for Journalists
Newswise Special Wire
Tuesday, January 8, 2019

Public edition | newswise.com

Newswise Cancer Research Wire for 08-Jan-2019
 

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.



Mayo researchers find ‘unacceptable low’ cervical cancer screening rates

The percentage of women who are screened for cervical cancer may be far lower than national data suggests, according to a Mayo Clinic study recently published in the Journal of Women’s Health.

– Mayo Clinic

Journal of Women’s Health.

Embargo expired on 07-Jan-2019 at 07:00 ET


New Approach May Curb Treatment-Related Skin Fibrosis in Cancer Patients

A clinical-scientific team specializing in head-and-neck cancer has identified a way to manipulate metabolism to potentially curb skin fibrosis - a common side effect of radiotherapy affecting quality of life of cancer survivors.

– University Health Network (UHN)

Nature Metabolism, Jan-2019

Embargo expired on 07-Jan-2019 at 11:00 ET


Mayo Clinic descubre marcadores biológicos para guiar el tratamiento del cáncer de próstata

Un estudio de Mayo Clinic descubrió que las alteraciones genéticas en el cáncer de próstata de bajo riesgo diagnosticado mediante biopsia por aguja pueden identificar a los hombres que corren más riesgo de cáncer en la glándula prostática.

– Mayo Clinic

Mayo Clinic Proceedings


الباحثون لدى Mayo يكتشفون انخفاضًا غير مقبول في معدلات فحص سرطان عنق الرحم

روتشستر، مينيسوتا — من الملاحظ أن نسبة النساء اللاتي أُجري لهن فحص سرطان عنق الرحم تقل بنسبة كبيرة عمّا تقترحه البيانات في الولايات المت...

– Mayo Clinic

Journal of Women’s Health


Mayo Clinic descobre marcadores biológicos que podem servir como guia para o tratamento do câncer de próstata

Alterações genéticas no câncer de próstata de baixo risco, diagnosticado por biópsia com agulha, podem identificar homens que são portadores de câncer nas glândulas prostáticas com risco maior, segundo descoberta feita pela Mayo Clinic. A p...

– Mayo Clinic

Mayo Clinic Proceedings


Investigadores de Mayo consideran que la tasa de detección de cáncer del cuello del útero es “baja de forma inaceptable”

El porcentaje de mujeres que se somete a la detección para cáncer del cuello del útero es muy inferior a lo sugerido por los datos nacionales, informa un reciente estudio publicado en la Revista de la Salud Femenina.

– Mayo Clinic

Revista de la Salud Femenina


Personalized vaccine to be tested for the first time in patients with kidney cancer

By pairing a novel personalized cancer vaccine with a more established immunotherapy drug that is administered to patients in an innovative fashion, scientists at Dana-Farber Cancer Institute are testing a first-of-its-kind strategy aimed at improvin...

– Dana-Farber Cancer Institute


Tip Sheet: Advances in understanding colorectal cancer; early results in trial of immunotherapy for myeloma; HIV and lung cancer; and single-cell RNA-sequencing

Summaries of recent Fred Hutch research, with links for additional background and media contacts.

– Fred Hutchinson Cancer Research Center


“Christmas Berry” Plant Compound Could Fight Uveal Melanoma

A molecule derived from a type of primrose could prove to be a potent inhibitor of metastatic growth for a rare and aggressive cancer.

– Thomas Jefferson University

Molecular Cancer Research


Genetic testing does not cause undue worry for breast cancer patients

As genetic testing for breast cancer has become more complex, evaluating a panel of multiple genes, it introduces more uncertainty about the results. But a new study finds that newer, more extensive tests are not causing patients to worry more about ...

– Michigan Medicine - University of Michigan

JCO Precision Oncology; CA163233


Stopping Cancer from Recruiting Immune System Double Agents

Cancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the body; the tumors actually put myeloid cells to work helping them grow and metastasize (spread). A research team co-led by scie...

– Rush University Medical Center

Nature Communications


January Is Cervical Cancer Awareness Month

Mount Sinai Experts Weigh In On Diagnosis, Prevention, Risk & Treatment Options

– Mount Sinai Health System


Solid Tumor Genomic Sequencing can Reveal Coexistent Hematologic Malignancy

Investigators at Rutgers Cancer Institute have uncovered that some mutations detected with targeted genome sequencing of patients with solid tumors are a result of a group of hematologic malignancies known as myeloproliferative neoplasms (MPN). This ...

– Rutgers Cancer Institute of New Jersey

JAMA Oncology

Embargo expired on 03-Jan-2019 at 11:00 ET


Improved Overall Survival Shown in Pediatric Hodgkin Lymphoma Patients when Receiving Combined Modality Treatment

Research from Rutgers Cancer Institute of New Jersey shows improved overall survival at five years for pediatric patients with early-stage Hodgkin lymphoma when treated with chemotherapy followed by radiotherapy versus chemotherapy alone.

– Rutgers Cancer Institute of New Jersey

JAMA Oncology, Jan-2019

Embargo expired on 03-Jan-2019 at 11:00 ET


Study Shows New Way to Group Protein Kinases as Cancer Drug Targets

A new study published early online in Cell Chemical Biology led by Markus Seeliger, PhD, Associate Professor of Pharmacological Sciences in the Renaissance School of Medicine at Stony Brook University, takes a fresh approach to grouping kinases as po...

– Stony Brook University

Cell Chemical Biology

Embargo expired on 03-Jan-2019 at 12:00 ET


Mayo Clinic Discovers Biological Markers That Could Guide Treatment for Prostate Cancer

Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbor higher-risk cancer in their prostate glands, Mayo Clinic has discovered. The research, which is published in the January edition of Mayo Clinic Pr...

– Mayo Clinic

Mayo Clinic Proceedings


An Errant Editing Enzyme Promotes Tumor Suppressor Loss and Leukemia Propagation

UC San Diego researchers have found a stem cell enzyme copy edits more than 20 tumor types, providing new therapeutic target for preventing cancer cell resistance to chemotherapy and radiation.

– University of California San Diego Health

Cancer Cell


Landmark Mammography Study Highlights the Importance of Breast Cancer Screening

A landmark mammography study has found that women who receive annual breast cancer screenings will have a lower mortality rate and will benefit more from therapy upon diagnosis of breast cancer.

– UCSF Helen Diller Family Comprehensive Cancer Center

Cancer


Sex Differences Identified in Deadly Brain Tumors

New research led by Washington University School of Medicine in St. Louis suggests that tailoring treatments to men and women with glioblastoma based on the molecular subtypes of their tumors may improve survival for all patients.

– Washington University in St. Louis

Science Translational Medicine. Jan. 2, 2019; R01 CA174737, R01 NS060752, R01 CA164371, U54 CA210180, U54 CA143970, U54 CA193489, K08 NS081105, R01 NS094670, U01 CA168397

Embargo expired on 02-Jan-2019 at 14:00 ET


Sepsis Kills More People Than Heart Attacks; New Tests in AACC’s The Journal of Applied Laboratory Medicine January Issue Could Help Rein In This Deadly Condition

In this special Sepsis Issue, AACC’s The Journal of Applied Laboratory Medicine highlights the cutting-edge clinical tests that laboratory medicine experts are developing to combat sepsis, a life-threatening condition that kills more people in the ...

– American Association for Clinical Chemistry (AACC)

The Journal of Applied Laboratory Medicine, Jan-2019


Real Housewives of Atlanta’s Gregg Leakes Decides Against Chemotherapy after Surgery for Colorectal Cancer

Are you a Real Housewives fan? If so, you probably know that the show has recently brought colorectal cancer to the spotlight … again. If not, we’ll catch you up quickly.

– Fight Colorectal Cancer


Single-Incision Surgery Speeds Recovery for Cancer Patient

A new robotic surgery device allows for all of the necessary surgical tools to be inserted through one 1-inch hole, whereas standard laparoscopic surgery requires five or six small incisions.

– UT Southwestern Medical Center


Best of 2018: Healthcare policy and research

Experts and research on important topics in the healthcare system

– Newswise


HSS Receives Half Million Dollar Grant to Investigate How to Improve Health Care System for Chronically Ill Adolescents

The "I'm Not Done Yet" Foundation" on Long Island has pledged a $500,000 research grant to Hospital for Special Surgery in New York City to establish best practices to meet the changing needs of young patients as they become teenagers and young adul...

– Hospital for Special Surgery


2018: Cedars-Sinai Cancer Investigators Pioneer Novel Research, Targeted Therapies

Cedars-Sinai Cancer drove major advances in cancer research in 2018. Among these was a study about a pancreatic cancer drug, Metavert, developed by Cedars-Sinai investigators to prevent the most common type of pancreatic cancer from growing and sprea...

– Cedars-Sinai

Journal of Clinical Oncology ; Dermatologist; Gastroenterology


A Resolution for Good Health

Rutgers Cancer Institute experts share more about the importance of preventative screenings for colorectal and lung cancers.

– Rutgers Cancer Institute of New Jersey


Organ-sparing treatments effective for bladder cancer; Brachytherapy cost-effective treatment for prostate cancer

Traditionally, treatment for muscle-invasive bladder cancer is chemotherapy followed by the removal of the bladder. However, researchers have data suggesting that treatment consisting of limited surgery followed by chemotherapy and radiation is just ...

– Beaumont Health

Cancer Medicine 2018; 1-12; Brachytherapy 17 (2018) 852-857


2018: Advances in Neurology

Physician-researchers at Cedars-Sinai are available to discuss neuroscience findings from 2018. Several are detailed in this news release, including a study that found prolonged exposure to particulate matter in air pollution can cause changes in the...

– Cedars-Sinai

neurosciences at Cedars-Sinai


Yale Cancer Center scientists advise caution in immunotherapy research

In a new study by Yale Cancer Center (YCC), scientists suggest that as the number of clinical trials in cancer immunotherapy grows exponentially, some caution should be exercised as we continue to better understand the biology of these new therapeuti...

– Yale Cancer Center

CELL

Embargo expired on 20-Dec-2018 at 11:00 ET


Genome offers clues to esophageal cancer disparity

A change in the genome of Caucasians could explain much-higher rates of the most common type of esophageal cancer in this population, a new study finds. It suggests a possible target for prevention strategies, which preliminary work suggests could in...

– Michigan Medicine - University of Michigan

Gastroenterology; CA163059; CA967622; CA200113; CA009676; CA046592; CA158319


Cancer’s metabolism subject of trailblazing study

Understanding that altered metabolism in cancer has received renewed research interest, according to Abe Stroock, the William C. Hooey Director and Gordon L. Dibble Professor in the Smith School of Chemical and Biomolecular Engineering. His latest re...

– Cornell University

PLOS Computational Biology, Dec-2018


Elegant trick improves single-cell RNA sequencing

Researchers at Cornell – led by Iwijn De Vlaminck, assistant professor in the Meinig School of Biomedical Engineering – have come up with an elegant, low-cost method that solves that problem. And not only does it push single-cell genomics forward...

– Cornell University

Nature Methods, Dec-2018


New research explores policies on timely breast cancer diagnosis for underserved women

Delays in diagnosis and use of under-resourced health centers account for most racial and ethnic disparities when it comes to a timely breast cancer diagnosis, according to a new study.

– University of Illinois at Chicago

Cancer Epidemiology, Biomarkers & Prevention


Georgetown Genetic Counselor Offers Insight On Direct-to-Consumer DNA Testing Kits

Direct-to-consumer DNA testing kits are expected to be a popular holiday gift this year, with 100 million people expected to have used one by 2020—but an expert genetic counselor at Georgetown says consumers should understand a few pros and cons be...

– Georgetown University Medical Center


Nuclear Medicine? It’s Probably Not at All What You Think It Is

The often-misunderstood specialty employs low doses of radioactive materials and advanced imaging technologies to diagnose and treat a variety of diseases.

Expert Available

– Wake Forest Baptist Medical Center


Researchers Suggest Current Methods for Reporting Toxicities in Cancer Clinical Trials are Falling Short

Findings published in JNCCN-Journal of the National Comprehensive Cancer Network examine the differences between patient- and clinician-reported outcomes; recommend a greater focus on the cumulative effect of multiple low-level toxicities.

– National Comprehensive Cancer Network® (NCCN®)

JNCCN—Journal of the National Comprehensive Cancer Network

Embargo expired on 19-Dec-2018 at 09:15 ET


Neoantigen vaccine spurs immune response in glioblastoma

In a report published in Nature, however, scientists at Dana-Farber Cancer Institute say they have shown that a personalized ‘neoantigen’ vaccine can spur a response against glioblastoma, with immune T-cells generated by the vaccine migrating int...

– Dana-Farber Cancer Institute

Nature

Embargo expired on 19-Dec-2018 at 13:00 ET


Researchers Discover How to Overcome Drug Resistance in Deadliest Cancers With Few Available Targeted Therapies

Mount Sinai researchers have discovered a new drug combination that could provide the first targeted therapy for some of the deadliest cancers, as well as molecular predictors of tumor response to the therapy, according to a study published in Cell R...

– Mount Sinai Health System

Cell Reports, Jan-2019

Embargo expired on 02-Jan-2018 at 11:00 ET


Announcements


John Mendelsohn, MD Anderson President Emeritus, Passes Away

John Mendelsohn, M.D., president emeritus of The University of Texas MD Anderson Cancer Center and an internationally acclaimed leader in the field of medicine and scientist whose research helped pioneer a new type of cancer therapy, died Jan. 7 at h...

– University of Texas M. D. Anderson Cancer Center


Hackensack University Medical Center Holds Third Annual Graduation Ceremony for Nurses in Blood and Marrow Transplant Fellowship Program

Hackensack Meridian Health Hackensack University Medical Center recently held the third annual Blood and Marrow Transplant (BMT) RN Fellowship Graduation Ceremony for nine registered nurses. The nurses are from 8PE and 8PW Blood and Marrow Transplant...

– Hackensack Meridian Health


# 1 in NIH Funding for Second Consecutive Year

With $13.4 million dollars in awards from the National Institutes of Health (NIH), the University of Pennsylvania School of Nursing (Penn Nursing) retains its top spot for research funding for the 2018 fiscal year, among other schools of nursing. Thi...

– University of Pennsylvania School of Nursing


Northwestern Urology Program Receives $10M Gift from the Polsky Family to Create a Urologic Cancer Institute

Northwestern Medicine received a $10 million gift to fund the creation of a new multidisciplinary institute dedicated to urologic cancers.

– Northwestern Medicine

Embargo expired on 07-Jan-2019 at 00:00 ET


Henry Ford Cancer Institute Enrolls First Patient in Pancreatic Cancer Research Study

The Henry Ford Cancer Institute announced today it has enrolled the first patient in a new clinical trial to test the effectiveness of using precise, higher dose MRI-guided radiation therapy to treat pancreatic cancer.

– Henry Ford Health System


MD Anderson notes passing of Waun Ki Hong – innovator, mentor, colleague

Waun Ki Hong, M.D., a trail-blazing physician-scientist and mentor whose clinical research innovations led to successful organ-sparing cancer treatment, advanced the field of targeted therapy and launched chemoprevention, died Wednesday at his home i...

– University of Texas M. D. Anderson Cancer Center


CMS Approves GIQuIC as a Qualified Clinical Data Registry for the 2019 Reporting Year

The GI Quality Improvement Consortium, Ltd. (GIQuIC) Registry has been approved as a Qualified Clinical Data Registry (QCDR) for reporting to the Merit-based Incentive Payment System (MIPS) for the 2019 reporting year. GIQuIC will host an information...

– American College of Gastroenterology (ACG)


Mount Sinai and Man Cave Health Launch Sports-Themed Resource Center

The Department of Urology at the Mount Sinai Health System has partnered with the nonprofit organization Man Cave Health to launch a first-of-its-kind sports-themed resource center for men that will provide educational resources on prostate health. ...

– Mount Sinai Health System


Soper Inducted into AIMBE College of Fellows

Steven Soper, PhD, member of The University of Kansas Cancer Center, was elected to the American Institute for Medical and Biomedical Engineering (AIMBE) College of Fellows.

– University of Kansas Cancer Center


Department of Defense Awards CWRU Researcher Nearly $1M to Study Prostate Cancer Drug Resistance

Sanjay Gupta, PhD, of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center will receive $962,000 over three years to investigate drug resistance mechanisms in prostate cancer. The funding is part of the...

– Case Western Reserve University

Department of Defense


Penn Medicine Telemedicine Pilots Second Opinions to Brain Tumor Patients

Brain tumor patients will now have access to Penn Medicine’s world-renowned cancer expertise through the launch of a new telemedicine second opinion program for brain tumors.

– Perelman School of Medicine at the University of Pennsylvania


James Terwilliger named as Executive Vice President and Chief Operating Officer at Dana-Farber Cancer Institute

New Executive Vice President and Chief Operating Officer named at Dana-Farber Cancer Institute

– Dana-Farber Cancer Institute


Marketplace


MD Anderson Cancer Center and Nanobiotix announce a large-scale, comprehensive clinical collaboration on NBTXR3

The University of Texas MD Anderson Cancer Center and Nanobiotix today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gast...

– University of Texas M. D. Anderson Cancer Center


MD Anderson Cancer Center and 4D pharma collaborate to evaluate live biotherapeutics in solid tumors

The University of Texas MD Anderson Cancer Center and 4D pharma today announced a strategic collaboration to evaluate 4D’s live biotherapeutic oncology pipeline across a range of cancer settings.

– University of Texas M. D. Anderson Cancer Center

Embargo expired on 06-Jan-2019 at 02:00 ET


MD Anderson Cancer Center and Ascentage Pharma announce strategic alliance in cancer drug development

The University of Texas MD Anderson Cancer Center and Ascentage Pharma Group, Inc. today announced a five-year strategic collaboration agreement to advance the development of five potential new cancer therapies.

– University of Texas M. D. Anderson Cancer Center

Embargo expired on 06-Jan-2019 at 15:00 ET


Expert Pitch


Experts Available: Cervical Cancer Awareness Month

– Rutgers University-New Brunswick

Tips

CUSTOMIZE YOUR FAVORITES WITH "MY READING LIST"

MY CHANNELS  |  SAVED ARTICLES  |  MY SOURCES  |  MY EXPERTS

MORE CHANNELS:
JOURNAL NEWS   |  TRENDS AND TOP STORIES   |  LOCAL NEWS  |  MEDICAL and SCIENTIFIC MEETINGS

Support
 Subscribe/Unsubscribe
 Edit My Preferences
 Comments/Suggestions
 Contact Us
 
Services
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 Michigan Medicine - University of Michigan

 Beaumont Health

  Newswise

 Washington University in St. Louis

 UT Southwestern Medical Center

 Stony Brook University

 University of California San Diego Health

 University of Texas M. D. Anderson Cancer Center

 Northwestern Medicine


Subscribe / Unsubscribe
Edit my preferences

© 2019 Newswise, Inc. All Rights Reserved.

215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417

 Contact Us